Everett Neville
Known title: See RemarksCIK: 0001641142
Associated companies
Transaction History
| CI | ▼ Sell | Open Market | 617 | $175K | 9/3/2026 | View on chart |
| CI | ▼ Sell | Open Market | 1,719 | $497K | 3/2/2026 | View on chart |
| CI | ▲ Buy | Grant | 2,602 | $0 | 2/27/2026 | View on chart |
| CI | ▲ Buy | Grant | 2,678 | $0 | 2/27/2026 | View on chart |
| CI | ▼ Sell | Tax Withholding | 883 | $254K | 2/27/2026 | View on chart |
| CI | ▼ Sell | Tax Withholding | 517 | $149K | 2/27/2026 | View on chart |
| CI | ▲ Buy | Option Exercise | 570 | $122K | 7/20/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 261 | $50K | 7/20/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 219 | $50K | 7/20/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 7,236 | $1.5M | 7/19/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 3,402 | $772K | 7/19/2023 | View on chart |
| CI | ▼ Sell | Open Market | 13,157 | $3.9M | 7/19/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 2,519 | $484K | 7/19/2023 | View on chart |
| CI | ▼ Sell | Open Market | 466 | $129K | 7/10/2023 | View on chart |
| CI | ▼ Sell | Open Market | 2,982 | $810K | 3/10/2023 | View on chart |
| CI | ▼ Sell | Open Market | 454 | $131K | 3/2/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 719 | $208K | 3/1/2023 | View on chart |
| CI | ▼ Sell | Open Market | 1,772 | $521K | 2/27/2023 | View on chart |
| CI | ▲ Buy | Grant | 4,694 | $0 | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 228 | $67K | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 1,683 | $495K | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 1,783 | $0 | 2/22/2023 | View on chart |
| CI | ▼ Sell | Open Market | 902 | $247K | 8/1/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 466 | $89K | 7/8/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 5,094 | $978K | 7/7/2022 | View on chart |
| CI | ▼ Sell | Open Market | 5,094 | $1.4M | 7/7/2022 | View on chart |
| CI | ▼ Sell | Open Market | 999 | $250K | 4/6/2022 | View on chart |
| CI | ▼ Sell | Open Market | 289 | $69K | 3/2/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 240 | $57K | 3/1/2022 | View on chart |
| CI | ▼ Sell | Open Market | 268 | $61K | 2/28/2022 | View on chart |
| CI | ▲ Buy | Grant | 1,414 | $0 | 2/25/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 224 | $51K | 2/25/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 415 | $95K | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 2,423 | $0 | 2/23/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 17 | $3K | 1/12/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 175 | $31K | 1/11/2022 | View on chart |
| CI | ▼ Sell | Open Market | 175 | $42K | 1/11/2022 | View on chart |
| CI | ▼ Sell | Open Market | 4,800 | $1.1M | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.